
Dr. Raphael Mechoulam
When it comes to researching the Cannabis plant there is one name that is synonymous. That name is Dr. Raphael Mechoulam. He was responsible for identifying tetrahydrocannabinol (THC), and then later cannabidiol (CBD).
He also identified the receptors that cannabis interacts with and all of the cannabiniods that bond to those receptors. To think we all have a cannabiniod system inside our bodies that work together with cannabis like the other systems we have. These systems include the Circulatory system, Lymphatic system, Nervous system, Endocrine system, Respiratory system, Digestive system, Urinary system. Your canabiniod system is what keeps the symbiotic relation going with Cannabis. It was meant to have a positive effect on our body system and be healthy for us, provided it’s ingested the right way. To say that our bodies were designed to get get high…well that doesn’t cut it.
“Is there more to learn about the cannabis plant and how it affects humans?”
“Because of administrative freezes [on research], there have been very, very few clinical studies. Although thousands of people use cannabis to fight cancer, there hasn’t been any clinical study, or a well-done, modern clinical study on cancer published. That’s a shame because if people use it, the data should be there. We should have modern clinical data. We did some clinical work on epilepsy 35 years ago and unfortunately nobody took great interest in that. And only five or six years ago all of a sudden people found that yes, our research is very relevant to what’s going on and many children today are being treated today with CBD, which we showed to be very active against epilepsy. There are very few drugs that help children with epilepsy. This should have been repeated on a larger scale in the U.S. We did a little work on PTSD and post-trauma. It should have been done on a large scale . . . All these things should have been done in the U.S. There is a major clinical trial on epilepsy. It should have been done 30 years ago after we published our small clinical paper. So that’s what’s missing. And I’m sorry about the situation.”
Dr. Raphael Mechoulam is retired now but has a lot of wisdom under his belt.